Christiana Bardon, MD, MBA, is a Managing Director of the UBS Oncology Impact Fund managed by MPM Capital. Chris is also the founder and Managing Member of Burrage Capital, a long short hedge fund in biotechnology and healthcare. Previously, she was a health care analyst at Fidelity Investments covering biotechnology, life science tools and diagnostics. She started her career as an analyst at MPM.

Chris earned her MS/BS from MIT, her MD magna cum laude from Harvard Medical School, and her MBA from Harvard Business School. While at Harvard Medical School, Chris was the recipient of a Howard Hughes fellowship. She also completed a residency in internal medicine at the Brigham and Women’s Hospital at Harvard Medical School. Chris currently serves on the Board of Fellows at Harvard Medical School and the Board of Trustees of the American Association of Cancer Research (AACR).